Phio Pharmaceuticals Corp. (PHIO) Financials

PHIO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 17.4 million 950000
Dec. 31, 2025 21.5 million 1.3 million
Sept. 30, 2025 11.5 million 1.7 million
June 30, 2025 11.3 million 1.2 million

PHIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.0 million 318000
Dec. 31, 2025 -2.1 million 274000
Sept. 30, 2025 -2.1 million 113000
June 30, 2025 -2.5 million 51000

PHIO Net Income

No data available :(

PHIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 17.0 million - -
Dec. 31, 2025 21.0 million - -
Sept. 30, 2025 10.7 million - -
June 30, 2025 10.8 million - -

PHIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 11.6 million
Dec. 31, 2025 11.6 million
Sept. 30, 2025 5.5 million
June 30, 2025 4.8 million

PHIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 2.8 million 1.4 million -
Dec. 31, 2025 - 1.5 million 1.1 million -
Sept. 30, 2025 7000 1.2 million 1.3 million -
June 30, 2025 3000 1.1 million 1.2 million -

PHIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 1000
Dec. 31, 2025 - 1000
Sept. 30, 2025 - 2000
June 30, 2025 - 1.1 million

PHIO

Price: $1.06

52 week price:
0.81
4.19

Earnings Per Share: -1.38 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 90800

Market Capitalization: 12.8 million

Links: